We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
It is with deepest regret that we announce the death of Professor Barrington Furr, one of our non-executive directors, who passed away on 27 February 2015.
MHRA has published the 9th edition of the advertising report Delivering High Standards in Medicines Advertising.
Dr Peter Nightingale has been appointed as chairman of the Medicines and Healthcare products Regulatory Agency’s (MHRA) Devices Expert Advisory Committee (DEAC).
Press statement in response to RUSI's report on organised crime and the illicit trade in tobacco, alcohol and pharmaceuticals (ON TAP) in the UK.
The Secretary of State for Health talks about NHS culture change and whistleblowing.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
We are aware of telephone calls made to a company recently from an individual who does not work for the agency claiming to be a member of MHRA staff.
Secretary of State for Health Jeremy Hunt statement on NHS whistleblowing and progress on implementing recommendations from Francis Inquiry.
A man has been given a 4 month prison sentence at Southwark Crown Court, suspended for 2 years, for the sale and supply of unlicensed erectile dysfunction drugs.
The Medicine and Healthcare products Regulatory Agency (MHRA) are today warning people who may have purchased an unlicensed medicine called GcMAF labelled as ‘First Immune’ from an online website or other unregulated sources.
It is hoped that the single site will help to improve the lives of patients and their families by developing medicines as quickly as possible.
Early and flexible input from MHRA facilitates successful flagship pharmaceutical site in UK.
Reclassification of Nexium Control 20mg Tablets announced by the Medicines and Healthcare products Regulatory Agency today (27 January 2015).
MHRA's response to EMA's recommendations to suspend medicines.
Health Research Authority (HRA) and Medicines and Healthcare products Regulatory Agency (MHRA) welcome public consultation.
Healthcare professionals are today being urged by MHRA to give women better information on the risks associated with valproate medicines.
Dr Angela Thomas replaces Professor Ian Weller who retired from the position and from CHM on 31 December 2014.
MHRA is asking people with a particular insulin pump to check the clock resets to the correct time and date when they change the battery or when the power is interrupted.
How MHRA and OxSonics help cancer drugs go the extra mile.
People will no longer be able to purchase diclofenac tablets, used to treat pain and inflammation, from pharmacies without a prescription from their doctor due to the small risk of heart problems.
MHRA took action to close down more than 1,600 websites illegally advertising and selling medicines last year.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).